130 related articles for article (PubMed ID: 3151340)
21. Large outbreak in a surgical intensive care unit of colonization or infection with Pseudomonas aeruginosa that overexpressed an active efflux pump.
Bertrand X; Bailly P; Blasco G; Balvay P; Boillot A; Talon D
Clin Infect Dis; 2000 Oct; 31(4):E9-E14. PubMed ID: 11049805
[TBL] [Abstract][Full Text] [Related]
22. [Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
Vincent P; Vachée A; Izard D
Pathol Biol (Paris); 1997 Nov; 45(9):771-5. PubMed ID: 9538477
[TBL] [Abstract][Full Text] [Related]
23. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
[TBL] [Abstract][Full Text] [Related]
24. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
Majumdar S; Kirby A; Berry N; Williams C; Hassan I; Eddleston J; Burnie JP
J Hosp Infect; 2004 Oct; 58(2):160-1. PubMed ID: 15474190
[No Abstract] [Full Text] [Related]
25. Pseudomonas cepacia in cystic fibrosis patients.
Prince A
Am Rev Respir Dis; 1986 Oct; 134(4):644-5. PubMed ID: 3094414
[No Abstract] [Full Text] [Related]
26. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of azithromycin as an antipseudomonal agent.
Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
[No Abstract] [Full Text] [Related]
28. Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa.
Tam VH; Schilling AN; Melnick DA; Coyle EA
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):145-51. PubMed ID: 15964503
[TBL] [Abstract][Full Text] [Related]
29. Clindamycin and metronidazole as independent risk factors for nosocomial acquisition of multidrug-resistant Pseudomonas aeruginosa.
Cipriano Souza R; Vicente AC; Vieira VV; Marques SG; Soares Md; Moura MC; Koifman RJ
J Hosp Infect; 2008 Aug; 69(4):402-3. PubMed ID: 18511147
[No Abstract] [Full Text] [Related]
30. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs.
Erlandsson M; Gill H; Nordlinder D; Giske CG; Jonas D; Nilsson LE; Walther S; Hanberger H
Scand J Infect Dis; 2008; 40(6-7):487-94. PubMed ID: 18584536
[TBL] [Abstract][Full Text] [Related]
31. Transfer of ceftazidime and aztreonam resistance from nosocomial strains of Xanthomonas (Stenotrophomonas) maltophilia to a recipient strain of Pseudomonas aeruginosa ML-1008.
Babálová M; Blahová J; Lesická-Hupková M; Krcméry V; Kubonová K
Eur J Clin Microbiol Infect Dis; 1995 Oct; 14(10):925-7. PubMed ID: 8605913
[No Abstract] [Full Text] [Related]
32. Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting.
Juan C; Gutiérrez O; Oliver A; Ayestarán JI; Borrell N; Pérez JL
Clin Microbiol Infect; 2005 Nov; 11(11):887-92. PubMed ID: 16216103
[TBL] [Abstract][Full Text] [Related]
33. [Sensitivity of pathogenic gram-negative microflora, isolated from patients in a surgical clinic, to the principal antibiotics, antiseptics, and disinfectants].
Iakimova VG; Markelov IM; Mel'nikova MIa; Lupanova NK; Iagunova RS
Gig Sanit; 1983 Dec; (12):73-4. PubMed ID: 6423455
[No Abstract] [Full Text] [Related]
34. [Mechanisms of resistance in Pseudomonas aeruginosa].
Cercenado Mansilla E; García Garrote F
Rev Clin Esp; 1998 Sep; 198 Suppl 2():10-6. PubMed ID: 9844472
[No Abstract] [Full Text] [Related]
35. Benzethonium chloride resistance in Pseudomonas aeruginosa isolated from clinical lesions.
Nakahara H; Asakawa M; Yonekura I; Sato A; Ohshima K; Kitamura M; Kozukue H
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):409-13. PubMed ID: 6435339
[TBL] [Abstract][Full Text] [Related]
36. [Drug susceptibility of Pseudomonas aeruginosa strains isolated from patients of a hospital and specialistic outpatients clinics of the SP ZOZ in Nidzica].
Pszenna M; Rokosz A; Luczak M
Med Dosw Mikrobiol; 2005; 57(3):303-10. PubMed ID: 16494207
[TBL] [Abstract][Full Text] [Related]
37. Current therapies for pseudomonas aeruginosa.
Giamarellou H; Kanellakopoulou K
Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
[TBL] [Abstract][Full Text] [Related]
38. [Characteristics and epidemiological significance of the Pseudomonas aeruginosa strains isolated in Rumania from sporadic cases and nocosomial infections].
Meitert E; Meitert T
Arch Roum Pathol Exp Microbiol; 1972 Sep; 31(3):443-8. PubMed ID: 4198514
[No Abstract] [Full Text] [Related]
39. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
[TBL] [Abstract][Full Text] [Related]
40. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
Triantafilo V; Fica A; Silva M; Thompson L
Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
